aTyr Pharma Statistics
NASDAQ: ATYRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.2462-0.0091 (-3.56%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
aTyr Pharma by the numbers
aTyr Pharma has a market capitalization of $24.1 million based on 98.09M shares outstanding. With trailing EPS of $-0.62, aTyr Pharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 44.3% below its 50-day average and 62.1% below its 200-day average.
Average daily trading volume is 3.24M shares, or about $797,545 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ATYR valuation vs. peer median
| Metric | ATYR | Peer median | Difference |
|---|---|---|---|
| Market cap | $24.15M | $19.76M | +22% |
| Avg. volume | 3.24M | 144.56K | +2141% |
Peer median across 8 companies: EVAX, SCLX, JSPR, ESLA, QNCX, DYAI, ALGS, TCRX.
Valuation
- Market cap
- $24.15M
- EPS (TTM)
- $-0.62
- Shares outstanding
- 98.09M
Price and trading
- Previous close
- 0.2553
- Open
- 0.2553
- Day range
- 0.246 – 0.2591
- 52-week range
- 0.246 – 1.12
- 52-week change
- -74.47%
- 50-day moving average
- 0.4419
- 200-day moving average
- 0.6498
- Beta
- —
- Volume
- 989.19K
- Average volume
- 3.24M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 24.15M
- Forward Pe
- -0.53
- Eps
- -0.62
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.12
- Week52 Low
- 0.25
- Avg Volume
- 3.24M
- Shares Outstanding
- 98.09M
- Ma50
- 0.44
- Ma200
- 0.65
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -78.02%
- Pct From52w Low
- 0.08%